NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

Children’s Hospital of Philadelphia Collaborates in Public Reporting of Pediatric and Congenital Heart Surgery Outcomes

2019 Report from Pennsylvania Healthcare Cost and Containment Council (PHC4) issued today

Children’s Hospital of Philadelphia (CHOP) is proud to once again collaborate with five other hospitals, the Society of Thoracic Surgeons (STS) and the Pennsylvania Health Care Cost Containment Council (PHC4) in the new public report issued today by PHC4 on outcomes of pediatric and congenital heart surgery. The 2019 report, the third issued by PHC4 since 2015, covers the years 2014 through 2017, reflecting the most recent data available to PHC4.

J. William Gaynor, MD, attending surgeon in the Cardiac Center at Children’s Hospital of Philadelphia

The report represents one of a few efforts at statewide public reporting on pediatric surgery outcomes, and according to PHC4, establishes Pennsylvania as a national leader in improving the health outcomes in children with heart disease. PHC4 is an independent state agency charged with collecting, analyzing and reporting healthcare-related information in Pennsylvania.

CHOP and the other participating hospitals, four others in Pennsylvania and one in Delaware, voluntarily provided data, including mortality rates, for 10 widely performed heart surgeries, to the STS National Congenital Heart Surgery Database. Using data from clinical registries such as the STS Database has been shown to provide a more accurate depiction of outcomes than do reports based on other data sources.

“This report by PHC4 provides key information to families who must consider treatment options for a child born with heart disease,” said J. William Gaynor, MD, a cardiothoracic surgeon at CHOP. “Collaborative efforts among surgeons, hospitals, professional organizations such as STS–and with state agencies like PHC4 are crucial to maintaining transparency of information for families, health officials and the general public.”

Affecting nearly one out of every 100 infants born in the U.S., congenital heart defects are the most common birth defect and the leading cause of deaths related to birth defects. Often affecting the structure and function of the heart, such defects may have a broad range of severity, from mild to severe. The PCH4 report provides hospital-specific volume (number of operations) and risk-adjusted in-hospital mortality data on 10 widely performed heart surgeries classified by the STS as benchmark procedures.

In addition to data on the 10 benchmark procedures, the report shows the total number of operations performed by each hospital—information that can be helpful in understanding a hospital’s overall experience with pediatric and congenital heart surgery. There were 6,696 pediatric and congenital heart surgeries performed in the six hospitals during the years 2014 through 2017. The report also looks separately at outcomes for neonates – infants less than 31 days old.

All the risk-adjusted 30-day operative mortality rates in the PCH4 report were either statistically the same as expected or better than the rates expected by national benchmarks. Ultimately, said Gaynor, “The results in the report show that families in Pennsylvania have multiple choices for quality pediatric heart surgery.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X